Volume 24, Number 12—December 2018
Research
Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant
Table 1
Characteristic | Result† |
---|---|
No. transplant recipients |
518 |
Organ transplanted | |
Kidney | 430 (83.0) |
Liver | 61 (11.7) |
Heart | 16 (3.1) |
Lung | 10 (1.9) |
Combined kidney and liver |
1 (0.2) |
Median age, y |
56 |
Sex | |
F | 203 (39.2) |
M |
315 (60.8) |
Prevalence of persistent biochemical hepatitis |
52 (10.2) |
Cause of biochemical hepatitis | |
Viral hepatitis‡ | |
Reactivation of chronic HBV infection | 5 (9.6) |
Chronic HCV infection | 7 (13.5) |
Chronic HEV infection | 5 (9.6) |
CMV reactivation | 8 (15.4) |
Nonviral causes† | |
Drug toxicity | 7 (13.5) |
Nonalcoholic fatty liver disease | 3 (5.8) |
Liver graft rejection | 7 (13.5) |
Biliary anastomotic stricture | 5 (9.6) |
Liver malignancies | 2 (3.8) |
Septic cholestasis | 2 (3.8) |
Recurrent pyogenic cholangitis | 1 (1.9) |
*CMV, cytomegalovirus; HBV, hepatitis B virus; HCV, hepatitis C virus; HEV, hepatitis E virus.
†All results are no. (%) unless otherwise indicated.
‡All percentages based on no. patients with biochemical hepatitis.
Page created: November 20, 2018
Page updated: November 20, 2018
Page reviewed: November 20, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.